LillyDirect Foundayo logo

LillyDirect Foundayo Review

8.1
★★★★☆4.1/5

GLP-1 weight-loss telehealth · Independently scored 8.1/10

Best for: the cheapest legal brand-name GLP-1

LillyDirect Foundayo scores highest on state availability and ease of access.

Orforglipron

$149/mo
Price rises with dose

Price checked on LillyDirect Foundayo’s site,

What the monthly price covers

Medication

Not stated

Provider visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
BrandFoundayoAll 50 StatesLilly Savings CardManufacturer Direct

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to LillyDirect Foundayo

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
LillyDirect Foundayo logo
4.1 / 5
Our editorial rating
Visit LillyDirect Foundayo →

from $149/mo · no insurance needed

LillyDirect Foundayo at a glance

Type
GLP-1 telehealth provider
Starting price
$149/mo (Regular self-pay price, 1-month (30-day) supply.)
Pricing model
Scales with dose: higher doses cost more
Availability
All 50 states
FDA status
3 FDA warning letters on record; see below

How we scored LillyDirect Foundayo

Each dimension is scored algorithmically from LillyDirect Foundayo’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

8.8/10

LillyDirect Foundayo's brand-name medication starts at $149/mo. Its value score is measured against the $179 median for GLP-1 providers, which compounded programs set, so brand-name sellers score lower on value by design. Note the price scales with dose, so budget for higher tiers as you titrate.

Effectiveness25%

8.5/10

LillyDirect Foundayo offers orforglipron, an oral GLP-1 with promising late-stage trial data. It prescribes FDA-approved brand-name medication rather than compounded versions.

User Experience15%

7.8/10

Online intake and platform experience; 5 platform features disclosed.

Trust & Safety15%

6.7/10

Key details fully confirmed by our editors; an FDA warning letter is on file (see flag above).

Accessibility10%

9.2/10

LillyDirect Foundayo treats patients in all 50 states plus DC.

Support10%

6.8/10

LillyDirect Foundayo provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this LillyDirect Foundayo review

Last checked August 2026
  • Confirmed current pricing across 6 dose/plan tiers
  • Confirmed availability in all 50 states plus DC
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.

What we checked

Provider's own pricing page
$25–$349/mo across 6 dose/plan tiers (checked August 2026)
FDA warning-letter register
An active letter is on file for this provider; see below

What to expect when you sign up with LillyDirect Foundayo

We walked LillyDirect Foundayo’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Talk to your own doctor to see if Foundayo (orforglipron) is right for you.
  2. 2Ask your doctor to send the prescription to LillyDirect Pharmacy.
  3. 3A pharmacy partner reaches out to confirm details, explore savings, and choose pharmacy options.
  4. 4Free home delivery or pickup at a retail pharmacy.
Price shown before you start
  • Self-pay prices shown publicly: from $149/mo (0.8mg) up to $349/mo (14.5mg & 17.2mg; $299 with the LillyDirect self-pay program if refilled within 45 days).
  • As low as $25/month for eligible commercially-insured patients; a Medicare Part D 'GLP-1 Bridge' program is referenced.
  • This is a manufacturer direct-to-patient pharmacy, not a telehealth prescriber: it requires an existing prescription from your own doctor, and there is no intake questionnaire on Lilly's side.
  • Lilly can help you 'find a doctor' via Healthgrades, but the clinical consult is third-party.
  • Fulfillment via third-party pharmacy partners with 24/7 pharmacist support.

GLP-1 medications LillyDirect Foundayo offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Foundayo (with commercial insurance + savings card)Insurance copay
$25/mo

Requires commercial insurance; Medicare/Medicaid not eligible. 'Starting at $25 per month'.

Foundayo 0.8 mg (self-pay)Brand-name
$149/mo
orforglipron

Regular self-pay price, 1-month (30-day) supply.

Foundayo 2.5 mg (self-pay)Brand-name
$199/mo
orforglipron

Regular self-pay price, 1-month supply.

Foundayo 5.5 mg & 9 mg (self-pay)Brand-name
$299/mo
orforglipron

Regular self-pay price, 1-month supply.

Foundayo 14.5 mg & 17.2 mg (self-pay)Brand-name
$349/mo
orforglipron

Regular self-pay price $349; available for $299 via an automatic purchase offer only if you complete your refill within 45 days of the delivery/receipt date of your previous Foundayo fill (14.5/17.2 mg only).

Medicare Part D Bridge Program (insurance-gated)Insurance copay
$50/mo

For eligible Medicare Part D patients. A bridge program, not a standing retail price.

Ready to get started?

Plans and promotions change often, so check LillyDirect Foundayo's current pricing and active discounts before you decide.

See LillyDirect Foundayo pricing →

What we like

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from the manufacturer, with no compounding and no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Watch-outs

  • Lower mean weight loss than Wegovy (14.9%) and Zepbound (20.9%): labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance; Medicare and Medicaid are not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

LillyDirect Foundayo: the drugmaker selling its own pill to you

Most providers on this site are telehealth companies or pharmacies that source a GLP-1 and resell it to you. LillyDirect Foundayo is something different: it is Eli Lilly, the manufacturer itself, selling its brand-name weight-loss pill straight to patients with no middleman, no compounding, and no reseller margin. Foundayo is the consumer brand for orforglipron, the first oral (pill-form) GLP-1 cleared for weight loss. If you have a valid prescription and you want the FDA-cleared branded product at the lowest price anyone is legally allowed to charge, this is the channel that sets the floor. The limit is that LillyDirect is a fulfillment pipe rather than a clinic: it will not see you, prescribe for you, or hold your hand.

How the pricing works (two completely different prices)

There are two Foundayo prices, and which one applies to you depends entirely on your insurance. If you are covered by commercial (employer or marketplace) insurance, the Lilly Savings Card brings your cost down to roughly twenty-five dollars a month, the cheapest legal path to any brand-name GLP-1 in 2026. That number comes from the manufacturer subsidizing its own list price to win the oral-GLP-1 market. Medicare and Medicaid patients are explicitly not eligible for that card, which knocks out a large share of the people who most want a cheaper option.

If you are paying cash, the price climbs with your dose. The entry dose starts at $149 a month, and the regular self-pay price steps up from there as you titrate to higher strengths, topping out in the mid-three-hundreds for the strongest doses. For reference, the category median is about $179, so the low doses undercut the field while the top doses sit near the middle. Lilly also runs an automatic refill offer that shaves the highest two doses down a notch, but only if you reorder within a tight 45-day window of your last delivery, so it rewards staying on schedule and penalizes gaps.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

  • Commercially insured: about twenty-five dollars a month with the Lilly Savings Card
  • Cash-pay, low dose: starts at $149/month
  • Cash-pay, high dose: scales up into the mid-three-hundreds, with a conditional refill discount on the top strengths
  • Medicare / Medicaid: not eligible for the savings card, so you pay cash rates

A daily pill, not an injection

Orforglipron is a once-daily oral GLP-1, with no needles, no auto-injectors, no refrigeration, and no compounding pharmacy in the chain. For people who have avoided GLP-1s purely because of the injection, that removes the single biggest barrier. It ships from LillyDirect's own pharmacy in all 50 states, so geography is not a problem the way it is with some compounders.

But the pill comes with a rule you have to respect: it must be taken on an empty stomach, with no more than a sip of water, and you wait about 30 minutes before eating, drinking, or taking other oral medications. Miss that window routinely and you blunt the drug. For a disciplined morning-routine person that is trivial; for someone with a chaotic schedule or other morning pills, it adds daily friction.

What it won't do: write your prescription

LillyDirect Foundayo is a pharmacy and pay channel. It does not include a medical visit, and it will not generate the prescription for you. You need a valid US prescription from a separate licensed prescriber (your own doctor, or an independent telehealth provider) before this channel can fill anything. So budget for that: a separate consult or visit fee somewhere else is part of the true cost of getting started here, even though the drug price looks low in isolation. Amazon One Medical solves that by pairing its clinicians with Amazon Pharmacy, which sells Foundayo.

How much weight loss to expect

Cheapest and easiest does not mean strongest. By the numbers in its own prescribing information, Foundayo's labeled-dose mean weight loss lands around 11%, which is clinically meaningful but below injectable semaglutide (Wegovy, in the neighborhood of 15%) and well below tirzepatide (Zepbound, around 21%). If your goal is the maximum possible weight loss and you can tolerate a weekly shot, an injectable will likely take you further. Foundayo's pitch is convenience, brand-name legitimacy, and price rather than peak efficacy.

Who should choose it, and who should skip it

  • Choose it if: you have commercial insurance and want a brand-name GLP-1 for about twenty-five dollars a month, you strongly prefer a pill over injections, or you specifically distrust compounded products and want the manufacturer's exact product.
  • Skip it if: you are on Medicare or Medicaid (no savings card), you want an all-in-one service that prescribes and ships together, you can't reliably hold the empty-stomach window, or you are chasing the largest possible weight loss and would do better on an injectable.

Trust and oversight

On product quality this is as straightforward as it gets. The drug is brand-name and FDA-approved, dispensed by the manufacturer's own pharmacy, with no compounding and no third-party sourcing. Eli Lilly does have active FDA warning letters: in September 2025 the agency cited three promotional videos for Zepbound and Mounjaro that left out risk information, and two of them mention LillyDirect. Those letters concern advertising, not the drug you receive. What you are NOT buying is clinical care: there is no built-in medical team monitoring your dose or side effects, because that responsibility stays with whoever wrote your prescription. So the oversight is excellent on product quality and intentionally absent on patient management. See our scoring methodology for how we weigh that split.

Bottom line

LillyDirect Foundayo is the price floor and the legitimacy benchmark for oral GLP-1s in 2026. If you are commercially insured and already have a prescriber, almost nothing beats it on cost-per-real-brand-drug, and the daily-pill format makes daily life easier for people who dislike injections. The trade-offs are equally clear: you bring your own prescription and your own clinical follow-up, the savings card excludes government insurance, the empty-stomach rule demands discipline, and the weight loss trails the strongest injectables. Buy it as a clean, cheap, manufacturer-direct supply of a brand-name pill, not for the full-service experience it doesn't pretend to offer.

The Bottom Line

LillyDirect Foundayo scores highest on state availability and ease of access.

Score: 8.1/10Best for: the cheapest legal brand-name GLP-1From: $149/mo

Ready to start with LillyDirect Foundayo?

From $149/mo. See current pricing and start your free consultation.

LillyDirect Foundayo might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If the lowest possible monthly price is your top priority, consider altRX (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare LillyDirect Foundayo vs…

LillyDirect Foundayo scores8.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

LillyDirect is Eli Lilly's official direct-to-consumer pharmacy channel, run by the drugmaker itself rather than a third-party reseller. It dispenses genuine, brand-name Lilly medications, including Foundayo (orforglipron), and ships them to patients who hold a valid prescription. Because it is Lilly's own channel, the products are the same FDA-approved drugs a retail pharmacy would fill.
Yes. LillyDirect is the manufacturer's own direct-pay pharmacy service, operated by Eli Lilly and Company, so you are buying authentic brand-name product straight from the maker with no compounding or middleman. That separates it from many telehealth sites that sell compounded (non-FDA-approved) versions of GLP-1 drugs. You still need a prescription from a licensed US clinician to order.
Yes. Foundayo is the brand name for orforglipron, an FDA-approved once-daily oral GLP-1 pill rather than a compounded product. As a finished, brand-name medication it is manufactured to FDA standards, unlike the compounded semaglutide or tirzepatide sold by some telehealth clinics. Take it exactly as prescribed and discuss whether it is right for you with a licensed clinician.
Patients with commercial insurance who use the Lilly Savings Card can pay as little as $25 per month; Medicare and Medicaid are not eligible for that card. For self-pay (cash) patients, the regular price for a 30-day supply is $149 for the 0.8 mg dose, $199 for 2.5 mg, $299 for the 5.5 mg and 9 mg doses, and $349 for the 14.5 mg and 17.2 mg doses. The two highest doses can drop to $299 through an automatic refill offer if you reorder within 45 days of your previous delivery.
You first need a valid prescription for Foundayo from a licensed US prescriber. LillyDirect fills prescriptions but does not write them, so it is not a telehealth clinic with its own doctors. Once you have a prescription, you can order through LillyDirect for home delivery in all 50 states. If you have commercial insurance, apply the Lilly Savings Card at checkout to access the lowest price.
Foundayo is a daily oral pill, while Wegovy (semaglutide) and Zepbound (tirzepatide) are weekly injections, and in trials Foundayo's average weight loss at its labeled dose (around 11%) has been lower than Wegovy's roughly 15% and Zepbound's roughly 21%. The trade-off is convenience and, for many, cost: no needles, no refrigeration, and a $25 price with commercial insurance and the savings card. Which option fits you depends on your goals, tolerance, and coverage, so decide with your clinician.
LillyDirect Foundayo doesn't use public promo or coupon codes. Third-party sites advertising "LillyDirect Foundayo discount codes" are typically fake; any current offer applies automatically through the link on this page.
The main red flag is an FDA warning letter on file, which this review flags. Read it before starting. We also note: Lower mean weight loss than Wegovy (14.9%) and Zepbound (20.9%): labeled-dose 11.1% per Foundayo PI; Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription); $25 savings card requires commercial insurance; Medicare and Medicaid are not eligible.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

Eli Lilly and Company, which runs LillyDirect, received an FDA warning letter dated September 9, 2025

The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this LillyDirect Foundayo review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.

See LillyDirect Foundayo's current pricing

Plans from $149/mo. Start your free consultation to check eligibility and today's price.